Patents by Inventor Nicolas Tzenios

Nicolas Tzenios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11915605
    Abstract: A method includes executing a diet recommendation process through a server to baseline an optimized diet to be recommended to a user with an elevated blood LDL level of 100-150 mg/dL and an elevated C-reactive protein level of >3 mg/L and/or an elevated ESR of >20 mm/hr based on performing statistical analyses on investigation data of a population of human subjects, and to modify a composition of the baselined optimized diet to be recommended to the user based on determining that adhering to the baselined optimized diet results in an increase in the elevated blood LDL level of the user accompanied by a decrease in the elevated C-reactive protein level and/or a decrease in the elevated ESR thereof and one or more parameter(s) of the user with reference to an additionally baselined optimal blood LDL level and an optimal blood C-reactive protein level and/or an optimal blood ESR.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: February 27, 2024
    Inventor: Nicolas Tzenios
  • Publication number: 20210118327
    Abstract: A method includes executing a diet recommendation process through a server to baseline an optimized diet to be recommended to a user with an elevated blood LDL level of 100-150 mg/dL and an elevated C-reactive protein level of >3 mg/L and/or an elevated ESR of >20 mm/hr based on performing statistical analyses on investigation data of a population of human subjects, and to modify a composition of the baselined optimized diet to be recommended to the user based on determining that adhering to the baselined optimized diet results in an increase in the elevated blood LDL level of the user accompanied by a decrease in the elevated C-reactive protein level and/or a decrease in the elevated ESR thereof and one or more parameter(s) of the user with reference to an additionally baselined optimal blood LDL level and an optimal blood C-reactive protein level and/or an optimal blood ESR.
    Type: Application
    Filed: October 17, 2019
    Publication date: April 22, 2021
    Inventor: Nicolas Tzenios